Explanipedia

Supporting Parents of Young Children with Type 1 Diabetes Through Telehealth: A Randomized Trial of the REDCHiP Intervention (Preprint) Open

Susana R. Patton, Nicole Kahhan, Holly K. O’Donnell, David D. Williams, Mark A. Clements , et al. · 2025

BACKGROUND Parents of young children with type 1 diabetes (T1D) are vulnerable to experiencing hypoglycemia fear (FH), an emotional condition that includes persistent and intense worry about hypoglycemia and/or use of unhealthful behavior…

The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes Open

Julia K. Mader, Jenise C. Wong, Guido Freckmann, José Garcia‐Tirado, Irl B. Hirsch , et al. · 2025

This consensus report evaluates the potential role of continuous glucose monitoring (CGM) in screening for stage 2 type 1 diabetes (T1D). CGM offers a minimally invasive alternative to venous blood testing for detecting dysglycemia, facili…

Corrigendum to “Intervention to reduce barriers to type 1 diabetes self-management: Diabetes Journey study design and participant characteristics” [Contemporary Clinical Trials 152 (2025) 107849]. Open

Kimberly A. Driscoll, Paige J. Trojanowski, Desireé N Williford, Holly K. O’Donnell, Erin Flynn , et al. · 2025

Parent Feedback on the Reducing Emotional Distress for Childhood Hypoglycemia in Parents (REDCHiP) Intervention: A Qualitative Analysis Open

Nicole Kahhan, MaryJane S. Campbell, Mark A. Clements, Kimberly A. Driscoll, Amy Milkes , et al. · 2025

Objectives: Severe hypoglycemia is more common among young children with type 1 diabetes mellitus (T1DM) than older youth, and parents report significant hypoglycemia fear (HF). Parents experiencing HF describe constant and extreme worry a…

Real‐world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes Open

Holly K. O’Donnell, Kimber M. Simmons, Stephen E. Gitelman, Terry Dex, Robert Hill , et al. · 2025

Aims This study surveyed individuals and caregivers of children who received teplizumab at stage 2 type 1 diabetes (T1D) to garner real‐world experiences and their health outlook for the future following treatment with the first approved d…

Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes Open

Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O’Neill, Tadej Battelino , et al. · 2024

Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes Open

Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O’Neill, Tadej Battelino , et al. · 2024

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programm…

Consensus guidance for monitoring persons with islet autoantibody-positive pre-Stage 3 type 1 diabetes Open

Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O’Neill, Tadej Battelino , et al. · 2024

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes (T1D) diagnosis and emerging availability of therapy to delay disease progression, T1D screening programs are be…

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes Open

Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O’Neill, Tadej Battelino , et al. · 2024

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programs…

The Maintain High Blood Glucose subscale of the child hypoglycemia fear survey: proposed preliminary cut points for screening youth with type 1 diabetes Open

Holly K. O’Donnell, Suzanne Bennett Johnson, Kimberly A. Driscoll · 2024

Objective To improve the clinical utility of the Maintain High Blood Glucose subscale of the Hypoglycemia Fear Surveys (HFS) by identifying clinically meaningful cut points associated with glycemic outcomes. Methods Youth (N = 994; 13.96 ±…

Historical Insights and Current Perspectives on the Diagnosis and Management of Presymptomatic Type 1 Diabetes Open

KIMBER M. SIMMONS, Brigitte I. Frohnert, Holly K. O’Donnell, Kimberly Bautista, Cristy Geno Rasmussen , et al. · 2023

Objective: The article provides practical guidance for (1) interpreting and confirming islet autoantibody screening results for type 1 diabetes (T1D) and (2) follow-up of individuals with early stages of T1D with the goal of …

Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High-Risk for Type 1 Diabetes Open

Holly K. O’Donnell, Cristy Geno Rasmussen, Fran Dong, Kimber M. Simmons, Andrea K. Steck , et al. · 2023

Objective: To assess anxiety and risk perception among parents whose child screened positive for islet autoantibodies, indicating elevated risk for type 1 diabetes.Research Design and Methods: The Autoimmunity Screening for Kids (ASK) stud…

Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High-Risk for Type 1 Diabetes Open

Holly K. O’Donnell, Cristy Geno Rasmussen, Fran Dong, Kimber M. Simmons, Andrea K. Steck , et al. · 2023

Objective: To assess anxiety and risk perception among parents whose child screened positive for islet autoantibodies, indicating elevated risk for type 1 diabetes.Research Design and Methods: The Autoimmunity Screening for Kids (ASK) stud…

Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes Open

Holly K. O’Donnell, Cristy Geno Rasmussen, Kimber M. Simmons, Andrea K. Steck, Brigitte I. Frohnert , et al. · 2023

OBJECTIVE To assess anxiety and risk perception among parents whose children screened positive for islet autoantibodies, indicating elevated risk for type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS The Autoimmunity Screening for Kids (A…

A randomized controlled clinical trial to improve health outcomes in youth with type 1 diabetes: Study design and baseline characteristics Open

Holly K. O’Donnell, Paige J. Trojanowski, G. Todd Alonso, Shideh Majidi, Janet K. Snell‐Bergeon , et al. · 2023

Psychometric Properties of the Hypoglycemia Fear Survey in a Clinical Sample of Adolescents with Type 1 Diabetes and Their Caregivers Open

Holly K. O’Donnell, Suzanne Bennett Johnson, Deseray Sileo, Shideh Majidi, Linda Gonder‐Frederick , et al. · 2021

Objective A previously published exploratory factor analysis suggested that the Hypoglycemia Fear Survey—Child and Parent Versions, is comprised of three subscales: Maintain High Blood Glucose, Helplessness/Worry About Low Blood Glucose, a…

Pump It Up! A randomized clinical trial to optimize insulin pump self-management behaviors in adolescents with type 1 diabetes Open

Holly K. O’Donnell, Tim Vigers, Suzanne Bennett Johnson, Laura Pyle, Nancy A. Wright , et al. · 2021

Graduated exposure to treat fear of hypoglycemia in a young adult with type 1 diabetes: A case study Open

Holly K. O’Donnell, Cari Berget, Jennalee S. Wooldridge, Kimberly A. Driscoll · 2018

Hypoglycemia is a common and dangerous complication of type 1 diabetes (T1D). Although some worry about hypoglycemia is adaptive, some individuals develop severe and impairing anxiety symptoms about hypoglycemic episodes. This presentation…

Holly K. O’Donnell YOU? Author Swipe